GTHX: G1 Therapeutics, Inc. Stock

by  •  • Comments Off on GTHX: G1 Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 208.28
Enterprise Value ($M) 227.61
Book Value ($M) 35.39
Book Value / Share 0.68
Price / Book 5.89
NCAV ($M) 28.79
NCAV / Share 0.55
Price / NCAV 7.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.52
Return on Assets (ROA) -0.30
Return on Equity (ROE) -1.07

Liquidity (mrq)
Quick Ratio 3.45
Current Ratio 3.87

Balance Sheet (mrq) ($M)
Current Assets 114.95
Assets 121.54
Liabilities 86.15
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 82.51
Operating Income -39.53
Net Income -47.97
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -38.34
Cash from Investing 2.81
Cash from Financing -26.91

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-21 13D/A Eshelman Fredric N 9.26 29.04

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 103,514 506,287 20.45
2024-04-24 73,494 332,100 22.13
2024-04-23 51,149 317,402 16.11
2024-04-22 71,437 155,689 45.88

(click for more detail)

Similar Companies
GLUE – Monte Rosa Therapeutics, Inc. GOSS – Gossamer Bio, Inc.
GRTS – Gritstone bio, Inc. HALO – Halozyme Therapeutics, Inc.
HLVX – HilleVax, Inc.


Financial data and stock pages provided by
Fintel.io